{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Travoprost+%280.004%25%29&page=2", "query": { "intervention": "Travoprost (0.004%)", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 28, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Travoprost+%280.004%25%29&page=3&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Travoprost+%280.004%25%29&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T18:14:19.074Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00051155", "title": "A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost (0.004%)", "type": "DRUG" }, { "name": "Latanoprost (0.005%)/Timolol (0.5%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-01", "completion_date": "2004-07", "has_results": false, "last_update_posted_date": "2008-08-05", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051155" }, { "nct_id": "NCT00051181", "title": "A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Angle-Closure", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost (0.004%)", "type": "DRUG" }, { "name": "Latanoprost (0.005%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2000-01", "completion_date": "2003-06", "has_results": false, "last_update_posted_date": "2008-08-05", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051181" }, { "nct_id": "NCT01336569", "title": "Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma" ], "interventions": [ { "name": "Travoprost 0.004%/timolol maleate 0.5% fixed combination", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2011-02", "completion_date": "2012-03", "has_results": true, "last_update_posted_date": "2013-07-08", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01336569" }, { "nct_id": "NCT00051142", "title": "A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Glaucoma, Open-Angle", "Ocular Hypertension" ], "interventions": [ { "name": "Travoprost", "type": "DRUG" }, { "name": "Latanoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2001-02", "completion_date": "2004-06", "has_results": false, "last_update_posted_date": "2008-08-05", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00051142" }, { "nct_id": "NCT00440011", "title": "Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost 0.03% eye drops", "type": "DRUG" }, { "name": "travoprost 0.004% eye drops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 266, "start_date": "2006-08", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2019-04-25", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00440011" }, { "nct_id": "NCT02097719", "title": "Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "bimatoprost 0.01%", "type": "DRUG" }, { "name": "travoprost 0.004%", "type": "DRUG" }, { "name": "timolol 0.5%", "type": "DRUG" }, { "name": "hypromellose 0.3%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2014-05", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-01-14", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Racine, Wisconsin", "locations": [ { "city": "Racine", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT02097719" }, { "nct_id": "NCT02730871", "title": "Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Open-angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension", "type": "DRUG" }, { "name": "Brinzolamide/brimonidine vehicle", "type": "DRUG" }, { "name": "Travoprost 0.004%/timolol 0.5% solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alcon Research", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 173, "start_date": "2016-06-24", "completion_date": "2018-07-13", "has_results": true, "last_update_posted_date": "2019-05-29", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Fort Worth, Texas", "locations": [ { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02730871" }, { "nct_id": "NCT01474135", "title": "AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "0.25% AR-12286 / 0.004% travoprost", "type": "DRUG" }, { "name": "0.5% AR-12286, 0.004% travoprost", "type": "DRUG" }, { "name": "0.004% Travoprost", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aerie Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 93, "start_date": "2011-12", "completion_date": "2012-04", "has_results": false, "last_update_posted_date": "2016-09-23", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 9, "location_summary": "Inglewood, California • Newport Beach, California • Petaluma, California + 6 more", "locations": [ { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Poway", "state": "California" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01474135" }, { "nct_id": "NCT00539526", "title": "Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Open Angle Glaucoma", "Ocular Hypertension" ], "interventions": [ { "name": "Bimatoprost 0.03%", "type": "DRUG" }, { "name": "travoprost 0.004%", "type": "DRUG" }, { "name": "latanoprost 0.005% eye drops", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergan", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 106, "start_date": "2007-09", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2019-04-24", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00539526" }, { "nct_id": "NCT01927406", "title": "The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Thyroid Eye Disease", "Ocular Hypertension", "Glaucoma" ], "interventions": [ { "name": "Prostaglandin Analog", "type": "DRUG" }, { "name": "Timolol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2014-06", "completion_date": "2016-12", "has_results": false, "last_update_posted_date": "2018-05-15", "last_synced_at": "2026-10-07T18:14:19.074Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01927406" } ] }